BBVA
IDXX icon

Banco Bilbao Vizcaya Argentaria’s Idexx Laboratories IDXX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6M Buy
24,013
+281
+1% +$158K 0.08% 181
2026
Q1 		$13.3M Sell
23,732
-1,184
-5% -$759K 0.09% 155
2025
Q4 		$16.9M Buy
24,916
+10,776
+76% +$7.34M 0.12% 136
2025
Q3 		$9.01M Buy
14,140
+10,943
+342% +$6.64M 0.07% 214
2025
Q2 		$1.71M Sell
3,197
-2,032
-39% -$972K 0.02% 421
2025
Q1 		$2.18M Sell
5,229
-275
-5% -$119K 0.02% 389
2024
Q4 		$2.27M Sell
5,504
-1,067
-16% -$468K 0.02% 385
2024
Q3 		$3.32M Sell
6,571
-2,126
-24% -$1.03M 0.03% 348
2024
Q2 		$4.25M Buy
8,697
+2,144
+33% +$1.08M 0.04% 287
2024
Q1 		$3.54M Buy
6,553
+3,426
+110% +$1.87M 0.04% 339
2023
Q4 		$1.74M Buy
3,127
+95
+3% +$44.6K 0.02% 459
2023
Q3 		$1.33M Buy
3,032
+37
+1% +$18.5K 0.02% 485
2023
Q2 		$1.5M Buy
2,995
+59
+2% +$28.3K 0.02% 454
2023
Q1 		$1.47M Buy
2,936
+427
+17% +$204K 0.02% 453
2022
Q4 		$1.02M Buy
2,509
+81
+3% +$31.4K 0.01% 489
2022
Q3 		$791K Sell
2,428
-48
-2% -$17.6K 0.01% 503
2022
Q2 		$868K Sell
2,476
-9,753
-80% -$3.98M 0.01% 484
2022
Q1 		$6.76M Sell
12,229
-295
-2% -$155K 0.09% 203
2021
Q4 		$8.28M Buy
12,524
+5,931
+90% +$3.72M 0.11% 162
2021
Q3 		$4.1M Sell
6,593
-80
-1% -$53.8K 0.06% 249
2021
Q2 		$4.21M Buy
6,673
+1,216
+22% +$671K 0.08% 237
2021
Q1 		$2.67M Buy
5,457
+642
+13% +$322K 0.05% 294
2020
Q4 		$2.41M Buy
4,815
+3,197
+198% +$1.43M 0.06% 296
2020
Q3 		$636K Buy
1,618
+162
+11% +$59.9K 0.02% 499
2020
Q2 		$480K Buy
1,456
+519
+55% +$150K 0.02% 556
2020
Q1 		$226K Buy
937
+30
+3% +$7.83K 0.01% 609
2019
Q4 		$236K Buy
+907
New +$239K 0.01% 655

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's IDXX Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria increased its Idexx Laboratories (IDXX) stake by 1.2% in Q2 2026, buying an estimated $158K and bringing the position to 24,013 shares worth $12.6M. The position accounts for 0.08% of the portfolio, ranked #181.

Banco Bilbao Vizcaya Argentaria first reported a position in IDXX in Q4 2019 and has held it in 27 quarters since. The position peaked at $16.9M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria held 24,013 shares of Idexx Laboratories worth $12.6M as of Q2 2026.
  • Banco Bilbao Vizcaya Argentaria bought 281 Idexx Laboratories shares in Q2 2026, an estimated $158K.
  • Idexx Laboratories made up 0.08% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #181 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Idexx Laboratories in Q4 2019 and has held it in 27 quarters since.
  • Banco Bilbao Vizcaya Argentaria's Idexx Laboratories position peaked at $16.9M in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.